The Challenge

AI-powered TechBio company based in Chicago, focused on breast cancer precision medicine. Their flagship product, TumorSight™ Viz, converts standard breast MRIs into 3D visualizations to support more informed surgical decision-making. FDA-cleared with 3 clearances to date. Strong overlap with the breast surgical oncology space,  direct alignment with PCB's MedTech positioning.